These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15812216

  • 21. Do different disorders in cell cycle regulation account for different biological behavior of urothelial and sinonasal inverted papillomas?
    Gunia S, Fritzsche F, May M, Liebe D, Koch S.
    Pathobiology; 2008; 75(1):34-41. PubMed ID: 18334838
    [Abstract] [Full Text] [Related]

  • 22. Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up.
    Mhawech-Fauceglia P, Fischer G, Beck A, Cheney RT, Herrmann FR.
    Eur J Surg Oncol; 2006 May; 32(4):439-44. PubMed ID: 16517112
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases.
    Lopez-Beltran A, Luque RJ, Moreno A, Bollito E, Carmona E, Montironi R.
    Virchows Arch; 2002 Aug; 441(2):148-53. PubMed ID: 12189504
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
    Cheng L, MacLennan GT, Zhang S, Wang M, Pan CX, Koch MO.
    Cancer; 2004 Jul 01; 101(1):183-8. PubMed ID: 15222005
    [Abstract] [Full Text] [Related]

  • 27. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D, Stenzinger A, Klauschen F, Stephan C, Jung K, Erbersdobler A, Rabien A.
    Pathobiology; 2011 Jul 01; 78(3):123-31. PubMed ID: 21613799
    [Abstract] [Full Text] [Related]

  • 28. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R, Epstein JI.
    Am J Surg Pathol; 2011 Sep 01; 35(9):1337-42. PubMed ID: 21836490
    [Abstract] [Full Text] [Related]

  • 29. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.
    Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M.
    Am J Clin Pathol; 2003 Jul 01; 120(1):93-100. PubMed ID: 12866378
    [Abstract] [Full Text] [Related]

  • 30. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, Cussenot O, Hamdy FC.
    J Urol; 2007 May 01; 177(5):1715-20. PubMed ID: 17437794
    [Abstract] [Full Text] [Related]

  • 31. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A, Montironi R, Blanca A, Cheng L.
    Hum Pathol; 2010 Aug 01; 41(8):1159-64. PubMed ID: 20381120
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT, Elmontaser G, Perkins DG, Yazdi HM, Stinson WA, Thijssen A.
    BJU Int; 2004 Sep 01; 94(4):544-7. PubMed ID: 15329109
    [Abstract] [Full Text] [Related]

  • 34. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
    Ramos D, Navarro S, Villamón R, Gil-Salom M, Llombart-Bosch A.
    Cancer; 2003 Apr 15; 97(8):1876-83. PubMed ID: 12673713
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
    Chang S, Lee S, Lee C, Kim JI, Kim Y.
    Urology; 2000 Mar 15; 55(3):448-52. PubMed ID: 10699635
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF, Epstein JI.
    Am J Surg Pathol; 2007 Mar 15; 31(3):390-7. PubMed ID: 17325480
    [Abstract] [Full Text] [Related]

  • 39. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G, Maurer S, Nagele U, Krug J, Bock C, Sievert KD, Stenzl A.
    Eur Urol; 2008 May 15; 53(5):1066-72. PubMed ID: 17980954
    [Abstract] [Full Text] [Related]

  • 40. Differentiation-dependent localisation of tissue-type plasminogen activator in human bladder urothelium.
    Makuc J, Masera A, Trsinar B, Jezernik K.
    Cell Biol Int; 2004 May 15; 28(5):381-6. PubMed ID: 15193281
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.